Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population

Clinical Therapeutics

Volumn 21, Issue 9, 1999, Pages 1539-1548

  Uygun, Ahmet ^a   Ates, Yüksel ^a   Erdil, Ahmet ^a   Kadayifci, Abdurrahman ^a   Cetin, Celalettin ^a   Gulsen, Mustafa ^a   Karaeren, Necmettin ^a   Dagalp, Kemal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Duodenal ulcer; Dyspepsia; Eradication; Helicobacter pylori; Omeprazole; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; ORNIDAZOLE; ROXITHROMYCIN; TINIDAZOLE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; DYSPEPSIA; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032840352     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80009-0     Document Type: Article

References (28)

1. National Institutes of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994;272:65-69.
2. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med. 1993;328:349-350.
3. Kadayifci A, Simsek H. Do Helicobacter pylori-positive duodenal ulcers have an increased risk of bleeding? Am J Gastroenterol. 1995;90:1901. Letter.
4. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 1994;55:19-23.
5. Glupezynski Y, Burette A. Drug therapy for Helicobacter pylori infection: Problems and pitfalls. Am J Gastroenterol. 1990;85:1545-1551.
6. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992;87:1716-1727.
7. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102:493-496.
8. Labenz J, Ruhl GH, Bertrams J, et al. Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. Am J Gastroenterol. 1994;89:726-730.
9. Simsek H. Kadayifci A, Tatar G. Low eradication rates of Helicobacter pylori with omeprazole plus amoxycillin combination in a Turkish population. Am J Gastroenterol. 1996;91:1062. Letter.
10. van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter. 1996;1:6-19.
11. Buckley MJM, Deltenre M. Treatment of Helicobacter pylori infection. Curr Opin Gastroenterol. 1997;13:56-62.
12. Labenz J, Stolte M, Peitz U, et al. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther. 1996;10:207-210.
13. Goddard A, Logan R. One-week low-dose triple therapy: New standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol. 1995;7:1-3.
14. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials. The MACH I Study. Helicobacter. 1996;1:138-144.
15. Hui WM, Lam SK, Ho J, et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci. 1991:36:577-582.
16. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med. 1995:333:984-991.
17. Hardy DJ, Hanson CW, Hensey DM, et al. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother. 1988;22:631-636.
18. Logan RPH, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multicentre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther. 1995;9:417-423.
19. Guay DR, Patterson DR, Seipman N, Craft JC. Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. Drug Saf. 1993;8:350-354.
20. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized double-blind trial. Am J Gastroenterol. 1993;88:1860-1864.
21. Simsek H, Kadayifci A, Tatar G. Short course of roxithromycin, nitroimidazine and omeprazole therapy for the eradication of Helicobacter pylori. Presented at the Digestive Disease Week and the 96th Annual Meeting of the American Gastroenterological Association; May 19-22, 1996; San Francisco, California. Gastroenterology. 1996;110:A259. Abstract.
22. Malizia T, Tejada M, Marchetti F, et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: A comparative in-vitro study. J Antimicrob Chemother. 1998;41:29-35.
23. Pavicic MJAM, Namavar F, Verboom T, et al. In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations. Antimicrob Agents Chemother. 1993:37:1184-1186.
24. Pounder RE, Williams MP. The treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997;11(Suppl 1):35-41.
25. Noach LA, Langenberg WL, Bertola MA, et al. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis. 1994;26:321-327.
26. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther. 1997;11(Suppl 1):45-53.
27. Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997;9:1-2.
28. Buke C, Aydin A, Gunsar F, et al. The susceptibility of Helicobacter pylori to various antibiotics. Turk J Gastroenterol. 1996; 7(Suppl 1):B55. Abstract. In Turkish.